E-LIB Suche - Ergebnisse für: Kroetz, D L

1

Large-scale space use of large juvenile and adult smalltoot..:

Graham, J ; Kroetz, AM ; Poulakis, GR...
Endangered Species Research. 44 (2021) - p. 45-59 , 2021

Link: https://doi.org/10.3354/..

2

Bevacizumab-induced hypertension and proteinuria: A genome-..:

Innocenti, F. ; Wang, J. ; Sibley, A....
European Journal of Cancer. 138 (2020) - p. S9-S10 , 2020

Link: https://doi.org/10.1016/..

3

ABC transporter polymorphisms are associated with irinoteca..:

Li, M ; Seiser, E L ; Baldwin, R M...
The Pharmacogenomics Journal. 18 (2016) 1 - p. 35-42 , 2016

Link: https://doi.org/10.1038/..

4

Transcriptomic variation of pharmacogenes in multiple human..:

Chhibber, A ; French, C E ; Yee, S W...
The Pharmacogenomics Journal. 17 (2016) 2 - p. 137-145 , 2016

Link: https://doi.org/10.1038/..

5

Clinical Pharmacogenetics Implementation Consortium Guideli..:

Martin, M A ; Hoffman, J M ; Freimuth, R R...
Clinical Pharmacology & Therapeutics. 95 (2014) 5 - p. 499-500 , 2014

Link: https://doi.org/10.1038/..

6

PP123—Target gene evaluation of two mirnas differently expr..:

Haenisch, S. ; Chhibber, A. ; Cascorbi, I..
Clinical Therapeutics. 35 (2013) 8 - p. e53-e54 , 2013

Link: https://doi.org/10.1016/..

7

Association of CYP2C9*2 With Bosentan-Induced Liver Injury:

Markova, S M ; De Marco, T ; Bendjilali, N...
Clinical Pharmacology & Therapeutics. 94 (2013) 6 - p. 678-686 , 2013

Link: https://doi.org/10.1038/..

8

Response to "CYP2C9 Polymorphism is Not a Major Determinant..:

Markova, S M ; Schwartz, J B ; Kroetz, D L
Clinical Pharmacology & Therapeutics. 95 (2013) 3 - p. 252-252 , 2013

Link: https://doi.org/10.1038/..

9

Clinical Pharmacogenetics Implementation Consortium Guideli..:

Martin, M A ; Klein, T E ; Dong, B J...
Clinical Pharmacology & Therapeutics. 91 (2012) 4 - p. 734-738 , 2012

Link: https://doi.org/10.1038/..

10

Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausa..:

Nakamura, Y. ; Ratain, M. J. ; Cox, N. J....
JNCI Journal of the National Cancer Institute. 104 (2012) 16 - p. 1264-1264 , 2012

Link: https://doi.org/10.1093/..

11

Functional Characterization of Liver Enhancers That Regulat..:

Kim, M J ; Skewes-Cox, P ; Fukushima, H...
Clinical Pharmacology & Therapeutics. 89 (2011) 4 - p. 571-578 , 2011

Link: https://doi.org/10.1038/..

12

The Pharmacogenomics of Membrane Transporters Project: Rese..:

Kroetz, D L ; Yee, S W ; Giacomini, K M
Clinical Pharmacology & Therapeutics. 87 (2009) 1 - p. 109-116 , 2009

Link: https://doi.org/10.1038/..

13

ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise:

Chinn, L W ; Kroetz, D L
Clinical Pharmacology & Therapeutics. 81 (2007) 2 - p. 265-269 , 2007

Link: https://doi.org/10.1038/..

14

Irinotecan-induced Diarrhea: Functional Significance of the..:

de Jong, F A ; Scott-Horton, T J ; Kroetz, D L...
Clinical Pharmacology & Therapeutics. 81 (2007) 1 - p. 42-49 , 2007

Link: https://doi.org/10.1038/..

15

The Pharmacogenetics Research Network: From SNP Discovery t..:

Giacomini, K M ; Brett, C M ; Altman, R B...
Clinical Pharmacology & Therapeutics. 81 (2007) 3 - p. 328-345 , 2007

Link: https://doi.org/10.1038/..